Market Data 
Markets
Replies to post #10178 on The Rising Influence of Rising Affluence
07/17/15 11:07 AM
08/02/15 12:25 PM
China will expand medical insurance to cover all critical illnesses for all urban and rural residents by the end of the year, the cabinet said on Sunday, the latest step in a plan to fix a healthcare system that has sparked public discontent.
The State Council said 50 percent of the medical costs will be covered by insurance in a bid to "more effectively reduce the burden of medical expenses", in a statement posted on the government's website
…China's healthcare spending is set to hit $1 trillion by 2020, up from $357 billion in 2011, according to McKinsey & Co…
09/30/15 8:41 PM
Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (ILMN) today announced a strategic collaboration to accelerate the adoption of precision medicine and targeted therapies in China.
Under the collaboration, Amoy will develop and commercialize a series of oncology-related tests based on Illumina’s next-generation sequencing (NGS) platforms, including the recently released research use only TruSight Tumor 15 as transferred from Illumina to Amoy.
10/01/15 9:44 AM
Teva Pharmaceutical Industries Ltd. today announced that it has entered into definitive agreements under which the Company will acquire Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa), a leading pharmaceutical manufacturing and distribution company in Mexico, along with a portfolio of products and companies, intellectual property, assets and pharmaceutical patents in Latin America and Europe in a debt-free, cash free set of transactions, for an aggregate of $2.3 billion.
Through this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets globally.
11/05/15 3:28 PM
China has launched a three-year pilot scheme to loosen approvals for new drugs, the country's food and drug regulator said on Thursday, as Beijing looks to help stimulate innovation in the country's pharmaceutical sector.
The trial, set to take place in 10 regions, will allow research and development bodies to seek drug approvals, which are currently restricted to drug manufacturers, the China Food and Drug Administration said in a statement on its website.
11/11/15 3:46 PM
India has taken a series of steps that eases norms for testing and clinical trials needed for introduction of drugs already approved in other countries.
The move places greater responsibility on the Ethics Committees - that vets clinical trials - and is expected to cut timelines for launch of new medicines, including biologics.
The Central Drug Standard Control Organization, through a Nov. 10 circular, said if a new drug was already approved outside India after conducting pre-clinical/toxicological studies on animals, such studies are not required to be repeated while approving their proposal for import or manufacture in India unless some specific concerns are raised.
11/13/15 4:15 PM
China has signalled a tougher stance on drug quality in the country's sprawling pharmaceuticals industry by rejecting applications for 11 medicines with inadequate or suspect clinical data.
The China Food and Drug Administration (CFDA) said in statement posted on its website on Nov. 11 that the move affected eight Chinese companies making generic drugs for heart problems, schizophrenia, pain, infections and other diseases.
11/18/15 6:04 PM
By 2020, an estimated 4.5 trillion doses of prescription drugs will be used by patients, up 24% percent [from] this year. In particular, increased usage is expected to jump in China, Brazil, India, and Indonesia, where the middle class is expected to swell and have greater access to health care, according to the IMS Institute for Healthcare Informatics, a unit of IMS Health, the market research firm.
12/16/15 1:42 PM
02/11/16 10:04 AM
AstraZeneca Plc, the U.K.’s second-largest drugmaker, plans to increase sales in Africa by almost 10 percent a year as the company seeks to capitalize on efforts by governments to improve health-care systems and fight conditions such as high blood pressure and cholesterol.
Construction is about to start on a manufacturing plant in Algeria costing “tens of millions of dollars... The factory will make drugs to treat cardiovascular disease, cancer and diabetes. AstraZeneca also has a plant in Egypt that manufactures drugs to lower blood pressure and cholesterol.
Africa’s pharmaceutical industry generated sales of $20.8 billion in 2013, compared with $4.7 billion a decade earlier, McKinsey and Co. said in June. The market may be worth as much as $65 billion by 2020…
01/06/17 4:45 PM
The world’s biggest drugmakers are racing to get in on the world’s fastest-growing health-care market. China's demand for pharmaceuticals has climbed by more than 10% annually over the past several years as the global market slowed. By 2020, China will overtake the U.S. as the largest pharmaceutical market on the planet, accounting for 7.5% of global sales, according to the consulting company IMS Health.
AI
